Pure Global

Apex multiple drug concentration semi-quantitative correction solution - Taiwan Registration fa474d37020bf21a859852b72e5913c3

Access comprehensive regulatory information for Apex multiple drug concentration semi-quantitative correction solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number fa474d37020bf21a859852b72e5913c3 and manufactured by MICROGENICS CORPORATION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
fa474d37020bf21a859852b72e5913c3
Registration Details
Taiwan FDA Registration: fa474d37020bf21a859852b72e5913c3
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Apex multiple drug concentration semi-quantitative correction solution
TW: ไบžๅŸนๅคš้‡่—ฅ็‰ฉๆฟƒๅบฆๅŠๅฎš้‡ๆ กๆญฃๆถฒ
Risk Class 2

Registration Details

fa474d37020bf21a859852b72e5913c3

DHA05603369903

Company Information

Product Details

This product is used to correct the Apex diazo base salt serum test set and the Apex tricyclic antidepressant test set on the Alinity c analyzer.

A Clinical chemistry and clinical toxicology

A.3200 Clinical Toxicology Corrector

Input;; QMS/QSD

Dates and Status

Nov 02, 2020

Nov 02, 2025